2 patients with R/R AML displayed successful outcomes when treated with PD-1 silenced CLL-1 CAR-T therapy, after the failure of HSCT and CD38 CAR-T therapy (53). The gene discussed is CLEC12A; the disease is acute myeloid leukemia.